PODD earnings date and last-quarter result: last quarter beat, P/E 36.87. Updated 2026-07-23.
Insulet (PODD) Research Hub
Insulet (PODD) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-10-26, shares last closed at 149.26 USD (+0.17%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 36.87, market cap 11.02B. This hub links to the full technical, earnings and options research available for PODD.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 149.26 USD (+0.17%) |
| 52-week range | 128.01 USD – 172.92 USD |
| Trend regime | Range |
| 14-day RSI | 75.5 (Overbought) |
| Trailing P/E | 36.87 |
| Market cap | 11.02B |
| Dividend yield | 0.00% |
Available research for PODD
Covered Call on PODD: how it works, illustrative setup around the real 149.26 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on PODD: how it works, illustrative setup around the real 149.26 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on PODD: how it works, illustrative setup around the real 149.26 USD price, max profit/loss, breakeven and when to use it. Educational.
PODD technical analysis: range, last 149.26 USD, RSI 75.5, 52w range 128.01 USD–172.92 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is PODD in?
Insulet (PODD) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is PODD in an uptrend or downtrend?
As of 2026-10-26, PODD is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is PODD's trailing P/E ratio?
PODD's trailing P/E is 36.87, with a market cap of 11.02B. See the earnings research page for full valuation detail.